Company

CNS Pharmaceuticals, Inc.

CNSP · CIK 0001729427

SEC FORM 4

$0.00

Disposition (code M) of 4,750 shares at $0 per share.

Reporting Person Levin Rami · Officer Title CEO and President · Transaction Code M

Traded Aug 14, 2026 · Disclosed Aug 18, 2026

Source: SEC Form 4 · 0001683168-26-006552 · filed 2026-08-18 · View filing →

SEC FORM 4

$10,000.00

Purchase of 2,000 shares at $5.00 per share.

Reporting Person Fisher Michal · Transaction Code P

Traded May 18, 2026 · Disclosed Aug 18, 2026FILED +92 DAYS

Source: SEC Form 4 · 0001683168-26-006553 · filed 2026-08-18 · View filing →